Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / Companies / Serum Life Science Europe GmbH
Entity

Serum Life Science Europe GmbH

Tracked across 1 events · 6 articles · First seen Apr 10, 2026 · Last active May 14, 2026

Sentiment
20
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 20
Tech
New TB Vaccines Show Limited Efficacy
Impact: Serum Life Science Europe GmbH developed the VPM1002 vaccine, one of the two new tuberculosis vaccines assessed in the PreVenTB trial.
Apr 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Serum Life Science Europe GmbH live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.